Sitemap - 2009 - The California Stem Cell Report
CSCR At Sea Until End of January
CIRM Issues for 2010: From Klein to Cash Flow to Conflicts
Sacramento Bee: CIRM is 'petri dish for patronage'
The Dark Side of Financing Stem Cell Research
Job Opening at CIRM for Administrative Assistant
CalAware: CIRM Not Serious About Transparency
Science vs. Salaries: What Do People Talk About?
Chiang Delays CIRM Oversight Meeting
Inside Biotech in San Diego: A Multibillion Dollar Matter
Stem Cell PR, Salaries and Mixed Messages
CIRM Identifies Training Grant Recipients
Torres Receives $225,000 Salary as CIRM Vice Chair
Prop. 71 Not Alone in Super, Super Majority Requirement
CIRM Pumps More Millions Into Training
Keirstead Leaves Co-Directorship at UC Irvine Stem Cell Center
CIRM Wants to Exceed the Legal Cap of 50 on Staff
Anonymous Comment Deleted; More Info Needed
CIRM Releases More Info on New Communications Move
Text of Consumer Watchdog Comments on CIRM Communications Proposal
Coverage Planned of CIRM Directors Meeting Wednesday and Thursday
Problems With CIRM's $1 Million, Free HQ Lease
Inside Stem Cell Funding: The Cost of Making a Grant
Venture Capitalist, Bankers to Weigh In on $500 Million Loan Program
Info Dribbling Out for CIRM Directors Meeting Wednesday
Art, Bill, Nadia and Stem Cell Billions
Changes Upcoming in $500 Million State Biotech Loan Program?
CIRM Approves $300,000 More for Tech Help, Including Grant Management
Coming Up at CIRM: Grant Triage and More Cash for Training, Translational Research
New Figures Show CIRM Spending $1.2 Million-plus for Grant Management
CIRM Grant Management Info and Costs
Buying BMWs and Grant Oversight
How to Handle Pesky Media Types
CIRM Directors to Discuss Agency's Management of $1 Billion in Grants
Scripps' Loring Teams with International Stem Cell Corp.
Biotech Firms: The Undead of Capitalism?
CIRM Releases Bank Info That It Once Withheld
CIRM's Openness Failures Raise Broader Questions
Some Question CIRM Grant Oversight as Excessive
$30 Million Available for Immunology Research
A Look at Tucson's Calimmune and $20 Milllion
Rundown on Grant Termination Stories
Torres Hails CIRM Innovation, Leadership
More on the Tale of Three Terminations
The Podesta Watch: White House Visits, Red Shoes and 61 Percent Gains
Scientist Magazine Picks Up Grant Termination Story
Nature on Disease Team Round: The Race is On
CIRM Scrutinizes Grantee Performance: The Tale of Three Terminations
CSCR Withholds Names of Terminated Grantees to Avoid Unnecessary Harm
Text of Csete's Description of CIRM Grant Monitoring
CIRM as Regulator, Compliance Enforcer
A $230 Million California Stem Cell Web
Off-Topic: Shades of Moby Dick
Blogger Talks to Novocell About First CIRM Loan
Disease Team News Coverage, Irony and a 'Sinking' State
NY Times: CIRM Moves Away From hESC
A Peek at News Coverage of CIRM's $230 Million Disease Team Round
CIRM News Release: More than $250 Million in Disease Team Round, Including International Partners
California Stem Cell Agency Approves $230 Million Aimed at Clinical Trials
Concerns About Size of Disease Team Round
City of Hope Wins Initial Appeal
City of Hope Grant Being Discussed
CIRM Directors Nix Buck Appeal
Buck Institute Application Being Discussed
Looking at CIRM Grant Appeals Issues
Weissman's $20 Million Proposal Dodges Rejection
Weissman's Grant and Appeal Now Being Discussed
Six Rejected Grant Applicants Make Public Appeal to CIRM Board
CIRM Board Recesses for Confidential Grant Review
Trounson's Report to Directors Posted by CIRM
Brighter Financial Outlook for CIRM
How the Lucky 11 Made Their Way: A $200 Million Tale
CIRM Board Meeting Available on Internet, $167 Million to be Handed Out
CIRM Hopes for Big Media Splash on Disease Team Grants
California Courts and CIRM: Both Troubled by Technology Problems
The Lucky 11 and $167 Million in Stem Cell Research Cash
CIRM Directors Review Loan Program Changes
Nature's Stem Cell Web Site Folds Tent
Rick Smacks Mazatlan, Blogger Escapes Damage
Tropical Storm Rick Takes Measure of Blogger and Boat
Hurricane Rick Plays Hob with Stem Cell Report
CIRM On Track to Hit $1 Billion Mark
Square 1 Wins CIRM Biotech Loan Pilot Project
CIRM Tackles $500 Million Biotech Loan Issues
CIRM Hires Levin to Help Find New VP
Klein Honored for Leadership on Stem Cells
CIRM Directors Take Up Revised Research Standards Oct. 27
CIRM Stem Cell Education Bill Signed into Law
Congressional Bill on hESC Research
CIRM Acts on Revised Research Standards This Week
California Treasurer Says Stem Cell Agency to Receive $118.5 Million
CIRM Says It Is Receiving More Cash From Bond Sale
No New Stem Cell Cash in Latest California Bond Sale
CIRM Panel Approves $300,000 Economic Study; Public Access to Data Still a Question
More Locations for Economic Impact Meeting
Will CIRM Withhold Economic Data?
CIRM Moving Forward with 'Vibrant' Economic Benefit Study
Prop. 71 Fallout: Bond Guru Assails California Voter Initiatives
CIRM Looking for Closer Conformity on Egg Rules
Germany Added to CIRM's Stable of Partners
Egg Donor Proposal Stirs Concern; CIRM Says Language is 'Placeholder'
Prop. 71 Minutia Stalls CIRM Again
Eggs, Donors, NIH Rules and More This Week
CIRM CEO To Gain More Power in Grant Reviews
CIRM Airs Powerful Patient Video
CIRM Nearing Agreement on Underwriters for $500 Million Biotech Loan Program
CIRM President to Gain More Clout in Competition for Millions in Grants
Shestack's Words Stir Ire in York
Research VP Slot Posted at California Stem Cell Agency
CIRM Backs Public Option in Health Care Reform
Good Faith, Loopholes and CIRM
CIRM Directors Approve $16 Million in Basic Research
Geron Travails a Reminder of Height of Stem Cell Hurdles
CIRM Rolls Back its Effort to Undercut Affordable Access
CIRM Directors Wrestle with Strategy and Ties to Business
Consumer Watchdog: Affordable Access to CIRM -Financed Therapies Threatened
Text of Consumer Watchdog's Therapy Access Letter
Stem Cell Star Search: Recruitment, Money and Conflicts
New Info on Pay Raises for Grant Reviewers
Whopping Pay Hike Proposed for CIRM Grant Reviewers
Salk CEO Brody Named to CIRM Board
Montana Lad Speaks Out on Scientists, Stem Cells and Obama
CIRM Presents 'Groaning Board' of Info for Next Week's Meeting
Research Standards Meeting Scheduled for Mid-September
Participation in CIRM Board Meeting Available in Southern California
A $100 Million Agenda Next Week for California Stem Cell Directors
CIRM Grant Reviewer Verfaillie Linked to Investigations in Minnesota
More Coverage on the New Research VP Position at CIRM
Support for Public Health Care Option, but "Nyet" to Hoover
CIRM Dwarfed in Biotech Patent Fight
Sizzling Month for Biotech; More on Patent Protection for Biotech
A Look Behind a 13-word Matter for CIRM Directors
The Podesta Watch: Public Health Care Option and Loans to College Students
The Meaning of "Further" and a $3 Billion Science Program
CIRM Seeks Help in Search for Csete Replacement
Call for CIRM Reform to be Heard by Agency Board
Text of Simpson Hoover Comments
Need Work? San Francisco Organization Offers Opportunities
CIRM Adds Info on Possible Endorsement of Public Insurance Option
CIRM Seeking More Industry Experience in Top Science Officer; New Post Proposed
Timely Info Well Serves CIRM and Public
The Podesta Watch: Mother's Milk, Appreciation and CIRM
Federal Lobbying and the CIRM Mission
Biotech's Financial Troubles and CIRM's New Loan Program
CIRM Grant Oversight Receives $150,000 Boost
New Info on CIRM's Grant Management Problems
CIRM Director Love Wades into the Trenches at CIRM
CIRM Directors Rebuff Five Reform Proposals
Candidates Reportedly On Line for CIRM Chief Scientific Officer Slot
CIRM's Troubled Grant Management System: A $1 Billion Oversight Matter
CIRM Made Last Minute Bid to Delay Hoover Report
Harrison Response on June 8 Letter
‘Boiling Blood,’ Biotech and Rainmaking
Trotter: Memories, Water and Life
Klein Warns Stem Cell Directors on CIRM Reform Proposal
The Bee on Hoover Report: Time for Candor
No IOUs for California stem cell researchers
California Stem Cell Agency to Hit Staffing Cap
Csete Discloses Reasons for Resignation: Lack of Respect at CIRM
Three Handlers Clear First Round in $500 Million Biotech Lending Program
Candidates Bid to Handle CIRM's $500 Million Loan Program
CIRM Director Responds to Hoover Commission Recommendations
A Tipping Point for CIRM? Reform Recommendations Coincide with Pressing Problems
CIRM Mishandles Reaction to Hoover Commission
Hoover Commission Recommendations
Excerpts Hoover Commission Investigation of CIRM
Sheehy Comments on Little Hoover Commission Recommendations and CIRM Reaction
Quick Links: Recommendations for CIRM Overhaul, Media Coverage and Reaction
CIRM News Release on Little Hoover Commission Report
Hoover Commission Report on CIRM Overhaul Out Today
Minimal Media Coverage of Csete's Resignation
CIRM Rips Hoover-recommended Reforms as Disruptive
Scientist Says Csete Resignation is Regrettable
Csete Resignation: Researcher Calls it Tragic
Csete Quits CIRM on Eve of Huge Grant Round
Text of Email on Csete Resignation
Stem Cell Board Tackles Troublesome Issues Next Week
Hoover Commission Moving Forward This Week on CIRM Changes
CIRM PR Puffs Fanciful Budget Number
Link to Bee Editorial Repaired
Bee Says Time is Ripe for Klein to Leave
Festering Issues Surface at Contentious Stem Cell Meeting
Klein's Misguided Budget Puffery
Mouse Breeding Plan Receives $3.8 Million from CIRM
CIRM Pulls Three Grants from Researchers
CIRM Training Programs Receive a $41 Million Boost
New CIRM Figures Show 25 Percent Budget Increase
More Info on CIRM's Finances and its Federal Patent Lobbying Position
Webcast of CIRM Board Meeting This Week
The $10 Billion Patent Litigation Bill
More on Klein's 2010 Departure Plans
CIRM Goes to Washington: Patents, Tornados and Bench Warming
CIRM Pulls a Grant, Aggressive Monitoring Reported
Snippets: Creation of Stem Cell Argonauts, Klein and Biotech Outsourcing
Stem Cell Research as Economic Development
$41 Million in Stem Cell Training Grants Look Good for CIRM Funding
CIRM Spending Plan Poorly Documented, Lacking Key Information
Klein to Leave CIRM Chairmanship in 18 Months
CIRM Directors Consider Millions in Grants, Industry-backed Federal Legislation and Agency's Budget,
Stem Cell Directors Ruffled by Voting Changes
CIRM Responds to Report on Future Industry Funding
CIRM Eyeing Major Reliance on Industry Cash
Patient Advocate Slams CIRM Reforms as Ludicrous
CIRM's Finances and Budget to be Examined Next Week
CIRM Board Meetings, Attendance and Discounts
A Research Perspective From a CIRM Scholar
Structural Changes in CIRM? Preliminary Thoughts from California's Good Government Agency
Klein Letter to Little Hoover Commission
Letter from CSCR to Little Hoover Commission
CIRM as a Lobbyist: Mission Creep, Industry Ties and Board Conflicts
More Bad Link Fixes on the Stem Cell Patent Flap
Fixing Link to LA Times Stem Cell Patent Column
Stem Cell Patent Flap Gains Wide Media Exposure
Little Hoover Hearing on CIRM on Wednesday
Consumer Watchdog Seeks Alteration of NIH Plan
Oceanside Firm Disappointed by NIH hESC Proposal
Latest CIRM Comments on NIH hESC Rules
CIRM Seeks Changes in NIH hESC Plans
CIRM Backs Biotech Industry Legislation, Aiming for Greater Federal Influence
More Info on CIRM Board Webcast
CIRM Debate on Federal Issues Available at Many Locations Throughout California
Podesta, CIRM and the Biotech Industry
Skimpy Coverage of CIRM Board Meeting
CIRM Approves $68 Million in Grants; Wrestles with Executive Evaluation
CIRM Debates Federal Legislation; $60 Million Grant Approvals Scheduled for Today
Controller Calls for Online Posting of Financial Holdings of CIRM Officials
Public CIRM Hearing Next Week on NIH hESC Rules
California's Stem Cell Education Bill Comes Before CIRM and Senate on Wednesday
Public Can Participate in CIRM Board Meetings at Stanford, Sacramento and Pleasanton
CIRM's Initial Assessment on NIH hESC Rules; Task Force to Develop More Analysis
CIRM Panel to Debate NIH Rules This Morning
CIRM Reassures Grantees on Their Cash
More on the $505 Million for CIRM
CIRM: Some Scientists' Grants to be Pulled
State Bond Sale Provides $505 Million for CIRM
Translational Grant Reviews Now Available From CIRM
CIRM Board Meeting Will be Available on the Internet
CIRM Provides Justification for $200,000 for ISSCR Meeting
CIRM to Hand Out $60 Million Next Week in Move Towards the Clinic
CIRM and the NIH: A Stand on the Proposed hESC Rules?
Torres, Palin and Stem Cell Research
Stanford's Weissman Flays Proposed NIH hESC Regs
CIRM Able to Fund Research Excluded by Proposed NIH Regulations
UC Sounds Cautionary Note on Stem Cell Therapy Amid 'Guarded Optimism'
San Diego's Stem Cell Consortium Still Hunting For Cash
Stem Cells and Cyberspace Info
New Stem Cell Patent Ruckus in California
Stem Cells and Three California Movers and Shakers
The California Stem Cell Story: Safety, Waste and Promises
Money for CIRM, But It Still Needs More
Hearing on Stem Cell Education Measure Coming Up
CIRM Not Obsessing Over Bond Sales
CIRM To Censor Confrontational Comments on its Facebook Site
CIRM Facebook Likely a Pioneer Effort Among State Agencies
CIRM Says Cash Will Come From This Month's Bond Sale
CIRM Bond Effort Still a Possibility
Cash Infusion for CIRM Confirmed
Cash Crunch Coming to an End at CIRM?
The Cartography of Stem Cell Science
Angell, Corruption and Medical Research
Time Now for CIRM to Let Sunshine In
Comments on the California Stem Cell Report
Novocell Patents and Potential Profits
CIRM Enters Battle Over Textbook Guidelines
LA Times Column Rips CIRM as Riddled with Conflicts and Sucking Up Precious Dollars
Prieto Dismayed by Bee Editorial on CIRM
Science Magazine on the State of CIRM
Luring CIRM Bond Buyers: What Cost to the State?
Big California Bond Sale Augurs Well For CIRM
Stem Cell Affordability Legislation Introduced in State Senate
Klein Promoting Stem Cell Issues in Washington
Snippets: CIRM Bonds, Clinicial Trials and TV Coverage
Torres-Roth Election: An Adroit Move for CIRM
Faster Posting of Comments Enabled on This Web Site
Timing Right for Sharing the Wealth on Federal Stem Cell Research
CIRM Director Sewell Criticizes Bee Editorial
The Bee: Dual Vice Chairs at CIRM Enhance Klein's Power
Stanford Reports on CIRM Finances
California Bond Funding: An Easing of Constraints
CIRM Watching Upcoming Bond Sales
Bernie Siegel Appearances in California
A Diversion: Rosemary, Garlic and Sourdough
Consumer Watchdog: New Role Needed for CIRM
CIRM Director Sheehy Decries Unfortunate Lack of Information
Torres-Roth Election Attracts Media Attention
CIRM Funding Priorities Presentation
CIRM Meeting Over, More News Coming
Clinic vs. Basic Research: CIRM Funding Priorities
CIRM Gives Go-Ahead on $17.5 Million Training Program, Funding Deferred on $41 Million Round
Roth and Torres Chosen as Vice Chairs of CIRM
CIRM Going With Taxable Bonds on its Private Sales Plan
Listening in on the CIRM Cash Woes, Vice Chair Election
Zach Hall on Monday Morning at the White House
Audiocast Available for CIRM Board Session Thursday
Dual Vice Chairs Coming Up for CIRM -- One From the World of Politics, One From Business
The NY Times, CIRM and Shifting Sands
Snippets from Obama Stem Cell Media Coverage
Waiting for Obama, Chapter 5 -- Be Careful What You Wish For
More Than You Want to Know about CIRM's Cash Crisis
Waiting for Obama Chapter 4 -- Political Thorns and hESC
Hear CIRM Board Live on its Financial Woes and Politically Charged Election of Vice Chair
New Counsel to President Hired at CIRM
Consumer Watchdog on Obama and CIRM
CIRM Calendar Hooha Raises Transparency Issues; Agency Says Calendars Cost $23 Each
CIRM Identifies Obama as Cash Source for Its Troubled Lab Projects
Obama Watch Chapter 3: Funding Ban to be Lifted on Monday
The Tale of CIRM´s 2009 Calendar
Stem Cell Bifurcation at the Vice Chairmanship Level
The 'Free Rides' Story: Petty Cash but Major Fallout
Executive Evaluation Procedures Posted for CIRM
$1 Billion for Stem Cell Labs: Troubles and Status
Overseeing Top CIRM Execs: A Reading of the Tea Leaves
CIRM Legal Costs Climb Towards $1 Million
What Bob Klein and CIRM Owe George Bush
Operator Error on Loring Comment
Burrill Says Biotech Industry Profitable for First Time in History
Fierce Biotech Poll: No Bailout for Biotech
California Bond Picture Not Too Bright, Say Bond Managers
A Caution about Excessive Industry Coziness at CIRM
The 'House of Cards' and a $400 Million Fund-Raising Drive
Who is on the Hook for $400 Million in Stem Cell Science?
California Passes Budget, Issuance of Stem Cell Bonds Still Distant
Chapter Two of 'Waiting for Obama' -- The Vagaries of Vagueness
CIRM Touts Its Financial Outlook
Long Wait for CIRM in the California Cash Queue
NY Times Examines the California Budget Mess that Ensnared CIRM
Science, Marco Polo and Kissing
Financially Troubled CIRM Hires $200,000 Federal Lobbyist
CIRM/ISSCR Convention Proposal Reduced to $250,000
Online Poll Says Nyet to Biotech Bailout; Results Subject to Instant Change
Mulling Industry Ties: CIRM, Charities and Cash
San Diego Consortium Pushing Ahead on $115 Million Lab
CIRM Finances and Grantee Uneasiness
CIRM Eyes Three Firms for $200,000 Lobbying Job
Torres Makes Pitch for Vice Chair's Job at CIRM
CIRM Launches Public Forums With Cast of Stem Cell Headliners
CIRM and the Stem Cell Industry: A Lobbying Question
Waiting for Obama -- The Stem Cell Delay
Nature's Niche Discusses CIRM Finances
CIRM Board Member Pizzo Writes About Stem Cell Budget Woes
Audience Numbers for First CIRM Audio-cast
CIRM's $200,000 Lobbyist Could Be at Work by Friday
Simpson On The CIRM Private Placement Plan
CIRM Vice Chair Story Surfaces in LA Times
CIRM Strategic Plan Hearings Begin Tomorrow
California State Treasurer Eyes Private Bond Sale -- First in State History
A Look Inside the Financial Woes at the California Stem Cell Agency
AP's Story on CIRM's Grants and Cash
Modest Coverage of CIRM Cash Problems
State Colleges Win CIRM Grants
"Bridges" Grants Approved by CIRM Board
CIRM Board to Act Today on Training Grants
CIRM Says California Stem Cell Report is 'One-Sided'
PBS News Hour Examines Stem Cell Research
California Stem Cell Money Woes in San Diego, Santa Barbara and San Francisco Area
CIRM Directors Wrestle With Bad News and Funding for Training
Dark Financial Outlook for CIRM Disclosed Tonight
Let's Hear Some Comments on CIRM's First Ever Webcast of a Board Meeting
CIRM Finance Documents Surface Online
New Instructions for CIRM Board Webcast
Bravo! Live Webcast of This Week's CIRM Board Meeting
More Info Up for Tomorrow's CIRM Board Meeting, But None on its Financial Condition
The California Stem Cell Agency and $435 Million in Budget 'Bafflegab'
CIRM Staff Nixes Appeal Efforts from Two Scientists
Rutgers' Young on Geron Trials
Trounson and the California Stem Cell Story
More Info for This Week's CIRM Board Meeting
Geron Price Still Moving Smartly Upward
Pluses and Minuses in the Geron News Coverage
Geron Stock Finishes Day up 36 Percent
From the Reed Family: A Thankful Perspective on the Geron Trials
Fresh Details on $500 Million Biotech Loan Plan and Underwriting
UCI Touts Role in Geron Trials
Stem Cell Stocks Rising on Geron's Good News
CIRM Publishes Reviews on $66 Million Grant Round; Names of Applicants Remain Secret
San Diego UT: California Stem Cell Effort Leads Nation
Geron Stock Soars 20 Percent on Approval of Clinical Trials
Klein Wants $10 Billion in Aid From Obama Administration
Stem Cell Research Funding in Lieu of Everything Else?
CIRM Vice Chairman Vote Delayed
Gravy Train Bedfellows: Catfish Farmers and California Stem Cell Research
Digging Into the Method of CIRM's Creation
CIRM Defends Its Spending, Positive Impact Cited
A California Stem Cell Question: Millions for Science vs. Cuts in Medical Help for the Poor
$500 Million CIRM Lending Program Up on Wednesday; Details Missing
Klein Ducks Little Hoover Questions
Reed Ethics Case Receives Modest Coverage
Burnham's Reed Warned by State Ethics Agency on Conflict of Interest
Ted Kennedy Backs Torres as CIRM Vice Chairman
CIRM's Financial Status, $500 Million Lending Program on the Table